Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Should Patients with Ischemic Stroke and Large Vessel Occlusions Go Directly to Endovascular Thrombectomy?
    STROKE ALERT

    Should Patients with Ischemic Stroke and Large Vessel Occlusions Go Directly to Endovascular Thrombectomy?

    August 1, 2020
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Time to Treatment with Endovascular Thrombectomy Remains a Critical Variable

    Acute Ischemic Stroke Due to Large Vessel Occlusion

    Large Vessel Ischemic Stroke Treatment

    Related Products

    Alzheimer’s Disease: What the Primary Care Physician Needs to Know

    All Access Subscription: Online

    Keywords

    stroke

    vessel

    endovascular

    thrombectomy

    reperfusion

    intravenous

    alteplase

    By Matthew E. Fink, MD

    Louis and Gertrude Feil Professor and Chair, Department of Neurology, Associate Dean for Clinical Affairs, New York Presbyterian/Weill Cornell Medical College

    Dr. Fink reports no financial relationships relevant to this field of study.

    SOURCE: Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 2020;382:1981-1993.

    Endovascular mechanical thrombectomy has become the standard treatment for patients with acute ischemic stroke caused by large vessel occlusion in both the anterior and posterior circulations. This is predicated on the ability to perform the procedure in a timely fashion or based on a mismatch between the size of infarction and brain perfusion.

    Endovascular thrombectomy has better outcomes than intravenous thrombolysis alone for large vessel occlusion, and an ongoing debate exists regarding the need for administering intravenous alteplase initially, followed by thrombectomy, or moving immediately to thrombectomy alone.

    In support of giving alteplase first is the observation that it may increase early reperfusion of the ischemic area and dissolve residual thrombi after endovascular thrombectomy. However, there is a risk that intravenous alteplase may delay mechanical thrombectomy and increase the risk of cerebral hemorrhage. These investigators undertook a strategy to determine whether endovascular thrombectomy alone would be noninferior to combined treatment with endovascular thrombectomy preceded by intravenous alteplase in patients with large vessel occlusion.

    This study was performed in 41 academic tertiary care centers in China. Patients with acute ischemic stroke from large vessel occlusion in the anterior circulation were randomly assigned in 1:1 ratio to undergo endovascular thrombectomy alone or endovascular thrombectomy preceded by intravenous alteplase within 4.5 hours after symptom onset. The primary analysis for noninferiority assessed the differences between the groups in the distribution of the modified Rankin scale scores at 90 days on the basis of a lower boundary of the 95% confidence interval of the odds ratio (OR) ≤ 0.8. Secondary outcomes also were assessed, including death and reperfusion of the ischemic area.

    Six hundred fifty-six patients were enrolled, with 327 assigned to the thrombectomy-alone group and 329 assigned to the combination therapy group. In regard to the primary outcome, endovascular thrombectomy alone was deemed noninferior to combined intravenous alteplase and endovascular thrombectomy (OR, 1.07; P = 0.04), but also was associated with a lower percentage of patients with successful reperfusion before thrombectomy (2.4% vs. 7.0%) as well as a lower overall successful reperfusion (79.4% vs. 84.5%). There was no difference in mortality at 90 days (17.7% vs. 18.8%).

    In an accompanying editorial (published May 6, 2020, on NEJM.org), Dr. Greg Albers noted that the timing of endovascular thrombectomy overlapped with the administration of alteplase, which might have diminished the thrombolytic effect of the medication. Also, the successful perfusion rate in the thrombectomy-alone group was lower than in other large published studies. There was no difference in intracerebral hemorrhages, nor a difference in procedure-related ischemic stroke.

    Thrombolysis may have been delayed because all patients were treated at a tertiary hospital, and the effects of earlier administration of alteplase, which is the standard in North America, could not be assessed.

    Dr. Albers closed his editorial with the following statement: “Until more data are available, it is appropriate to follow current guidelines that recommend that all eligible patients receive alteplase before thrombectomy.”

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Neurology Alert

    View PDF
    Neurology Alert (Vol. 39, No. 12) - August 2020
    August 1, 2020

    Table Of Contents

    Clinical Trials of IL-6 Inhibitors for the Treatment of Neuromyelitis Optica Spectrum Disorders

    Brachial Plexopathy Localization in Patients with Cancer

    Anticoagulation in Patients with Ischemic Stroke Related to Atrial Fibrillation, Following Reperfusion Therapy

    Treatment of Central Retinal Artery Occlusion with Intravenous Thrombolysis

    Widely Used in Asia, Cilostazol Appears Effective for Long-Term Secondary Stroke Prevention

    Should Patients with Ischemic Stroke and Large Vessel Occlusions Go Directly to Endovascular Thrombectomy?

    Mobile Stroke Units: What Is the Best Way to Use Them?

    COVID-19 Infection Increases Stroke Risk by Almost Eight Times the Stroke Risk with Influenza

    Ticagrelor Added to Aspirin Reduces Long-Term Risk of Recurrent Stroke or Death After Ischemic Stroke or TIAs

    We’d Love to Hear from You!

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Neurology Alert’s Editor in Chief Matthew Fink, MD; Peer Reviewer M. Flint Beal, MD; Editorial Group Manager Leslie Coplin; Editor Jason Schneider; Executive Editor Shelly Morrow Mark; and Accreditations Director Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2021 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing